Work

DOP077 Immunomodulatory effects of etrasimod (APD334), an oral, potent, next-generation, selective S1P receptor modulator

Year: 2017

Type: conference-abstract

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjx002.114

Authors: S.D. Lee, R. Christopher, L. Trokan, C. Lassen, J. Adams, M. Chiorean

Institutions: University of Washington Medical Center, Arena Pharmaceuticals (United States), Virginia Mason Medical Center, Virginia Mason Institute

Language: English

Topic: Sphingolipid Metabolism and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586904892

Cites:

Cited by: 3

Related to: 10